Melissa L Borthwick, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 89 S Mast Rd, Goffstown, NH 03045 Phone: 603-497-5661 Fax: 603-497-5740 |
News Archive
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
Ethiopia has taken crucial steps to fight the HIV/AIDS pandemic, but the east African country urgently needs external assistance if its efforts are to meet with success, a senior United Nations official said today.
Now that teens and young adults across the country account for an increasing share of COVID-19 cases, and many have become eligible for vaccination, several recently published studies based on polls of this age group provide insights into the kinds of messaging that might work best for both preventing transmission and vaccine uptake.
Lack of exercise and excessive weight are strongly associated with a type of heart failure that has a particularly poor prognosis, UT Southwestern Medical Center researchers determined in an analysis of data from three large studies.
› Verified 5 days ago